Answers are grounded in this paper and cite their sources.
The present study confirmed that treatment with rituximab was remarkably safe and allowed for a large percentage of complete or partial remissions in patients with MN.
No takes yet. Share an insight, caveat, or question.
Fiorentino et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: